Current evidence on major non-HLA antibody targets, including angiotensin II type 1 receptor, endothelin A receptor, perlecan fragment LG3, vimentin, major histocompatibility complex class I chain-related molecule A, collagen, fibronectin, natural antibodies, and glutathione S-transferase theta 1 is summarized and high...
R. Ryeed, E. A. Sidahmed, Aleena Sajid et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.